Peer-reviewed articleOpen access

Expanded access to psychedelic treatments: comparing American and Canadian policies.

Richard J iD, Garcia-Romeu A iD, Henningfield JE

General psychiatryFeb 19, 2025License: open accessUnited States7 citationsDOI: 10.1136/gpsych-2024-101894

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsychedelicsDepressionPTSD

Keywords

PsychopharmacologypsychotherapyStress Disorders, Post-traumaticHealth Care Quality, Access, And EvaluationDepressive Disorder, Treatment-resistant

View paper Full text (PDF)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsilocybin

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.

Haridy R

Europe PMC2023

ArticlePsilocybin

Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.

Portes MAM, Bertoglio LJ

Europe PMC2026

ArticlePsychedelics

Taking the tripping out of psychedelic medicine.

Dolgin E

Europe PMC2022